ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

QTEX vs DAVI // FORWARD P/E MULTIPLE

QTREX Quantum Ltd. (NASDAQ) VS. Davion Healthcare Plc (NASDAQ) • 15-METRIC TALLY: QTEX 2 — DAVI 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QTEX VS. DAVI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC QTEX DAVI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 0.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -13.49% — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 — — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.2 18.0 +28.19 QTEX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $73.9M $67.3M $6.6M QTEX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR QTEX REV DAVI REV QTEX GROSS % DAVI GROSS % QTEX FCF DAVI FCF
FY 2025 $289.0K — 0.7% — -$10.0M —
FY 2024 $0 — — — -$9.5M —
FY 2023 $0 — — — -$9.7M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QTEX // BETA —
DAVI // BETA —